Clinical Features of Status Epilepticus in Patients with HIV Infection
Neurol 65:314-316, Lee,K.C.,et al, 2005
Epileptic Seizures During Follow-up of Patients Treated for Primary Brain Tumors
Neurol 65:213-215, Hildebrand,J.,et al, 2005
Postcarotid Endarterectomy Hyperperfusion or Reperfusion Syndrome
Stroke 36:21-26, Karapanayiotides,T.,et al, 2005
Clinical and Magnetic Resonance Imaging Manifestations of Neurosarcoidosis
Semin Arthritis Rheum 34:649-661, Spencer,T.W.,et al, 2005
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Unusual Presentation of Neurocysticercosis: Report of Two Cases
Nepal Journal of Neuroscience 2:185-189, Gurung,G.,et al, 2005
Hyponatremia from Oxcarbazepine and Carbamazepine
Neurol 65:1976-1978, Dong,X.,et al, 2005
Use of Levetiracetam to Treat Tics in Chidlren and Adolescents With Tourette Syndrome
Movement Disorders 20:714-718, Awaad,Y.,et al, 2005
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
Treatment-Responsive Limbic Encephalitis Identified by Neuropil Antibodies: MRI and PET Correlates
Brain 128:1764-1777, Ances,B.M., et al, 2005
Diffusion-Weighted Imaging and Proton MR Spectroscopy of White Matter Abnormalities in a Case of Phenylketonuria
Eur J Radiol Extra 54: 5-9, Teksam,M.,et al., 2005
Diffusion-weighted and Perfusion MRI Demonstrates Parenchymal Changes in Complex Partial Status Epilepticus
Brain 128:1369-1376, Szabo, K.,et al, 2005
Central Nervous System Manifestations of Mycoplasma Pneumoniae Infections
J Infection 51:343-354, Tsiodras, S.,et al, 2005
Magnetic Resonance Imaging in Posterior Reversible Encephalopathy Syndrome: Report of Three Cases and Review of Literature
Arch Gynecol Obstet 271:79-85, Finocchi,V.,et al, 2005
Progressive Myoclonic Epilepsies: A Review of Genetic and Therapeutic Aspects
Lancet Neurol 4:239-248, Shahwan, A., et al, 2005
Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005
Imaging Manifestations of Neurosarcoidosis
AJR 182:289-295, Smith, J.K.,et al, 2004
Reversible Corpus Callosum Lesion in Legionnaires Disease
JNNP 75:651-654, Morgan, J.C.,et al, 2004
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004
Incidence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patent Foramen Ovale Closure Devices in 1,000 Consecutive Patients
J Am Coll Cardiol 43:302-309, Krumsdorf,U.,et al, 2004
Incidence of Thrombus Formation on the CardioSEAL and the Amplatzer Interatrial Closure Devices
Am J Cardiol 93:426-431, Anzai,H.,et al, 2004
Clinical Correlations of Mutations in the SCN1A Gene: From Febrile Seizures to Severe Myoclonic Epilepsy in Infancy
Pediatr Neurol 30:236-243, Ceulemans,B.P.G.M.,et al, 2004
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Myocardial Infarction Following Brief Convulsive Seizures
Neurol 63:2453-2454, Chin,P.S.,et al, 2004
Preclinical Alzheimer Disease
Neurol 63:2341-2347, Saxton,J.,et al, 2004
Clinical Evaluation of Idiopathic Paroxysmal Kinesigenic Dyskinesia
Neurol 63:2280-2287, Bruno,M.K.,et al, 2004
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Systematic Screening Allows Reduction of Adverse Antiepileptic Drug Effects
Neurol 62:23-27, Gilliam,F.G.,et al, 2004
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
Yield of Screening for New Aneurysms After Treatment for Subarachnoid Hemorrhage
Neurol 62:369-375,354, Wermer,M.J.H.,et al, 2004
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Epilepsy
JAMA 291:654, Parmet,S, 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Lateralizing Value of Todd's Palsy in Patients with Epilepsy
Neurol 62:289-291, Kellinghaus,C.&Kotagal,P., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Postpartum Angiopathy with Reversible Posterior Leukoencephalopathy
Arch Neurol 61:411-416, Singhal,A.B., 2004
Cognitive Side Effects of Antiepileptic Drugs in Children
Neurol 62:872-877, Loring,D.W.&Meador,K.J., 2004
The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004
Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Percutaneous Closure of Patent Foramen Ovale Reduces the Frequency of Migraine attacks
Neurol 62:1399-1401, Schwerzmann,M.,et al, 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Closure of a Patent Foramen Ovale is Associated with a Decrease in Prevalence of Migraine
Neurol 62:1439-1440, Post,M.C.,et al, 2004
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004